Patrizia Vici

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Neoplasm Drug Resistance

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
De Luca C; Vici P; Carpano S; Sergi D; Viola G; Corsetti S; Toglia G; Pinnarò P; Vizza E; Amodio A; Paoletti G; Lopez M
Recent advances in the adjuvant treatment of early breast cancer.
Vici Patrizia; Giotta Francesco; DI Lauro Luigi; Brandi Mario; Gebbia Vittorio; Foggi Paolo; Lorusso Vito; Vitucci Carlo; Sergi Domenico; Fattoruso Silvia Ileana; Giannarelli Diana; Viola Giuditta; Corsetti Serena; Colucci Giuseppe; Lopez Massimo
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti F R; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso S I S; Lopez M
Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Patrizia Vici (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: De Luca C; Vici P; Carpano S; Sergi D; Viola G; Corsetti S; Toglia G; Pinnarò P; Vizza E; Amodio A; Paoletti G; Lopez M
Recent advances in the adjuvant treatment of early breast cancer.
La Clinica terapeutica 2009;160(4):299-306.
2009: Vici Patrizia; Giotta Francesco; DI Lauro Luigi; Brandi Mario; Gebbia Vittorio; Foggi Paolo; Lorusso Vito; Vitucci Carlo; Sergi Domenico; Fattoruso Silvia Ileana; Giannarelli Diana; Viola Giuditta; Corsetti Serena; Colucci Giuseppe; Lopez Massimo
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines.
Anticancer research 2009;29(5):1841-5.
2008: Vici P; Viola G; Rossi S; Botti C; Vitucci C; Sergi D; Ferranti F R; Saracca E; Di Lauro L; Corsetti S; Foggi P; Fattoruso S I S; Lopez M
Optimal sequence of anthracyclines and taxanes as adjuvant breast cancer treatment.
La Clinica terapeutica 2008;159(6):453-6.
2008: Vici P; Viola G; Botti C; Rossi S; Vitucci C; Corsetti S; Di Lauro L; Sergi D; Foggi P; Perri P; Tirelli C; Mottolese M; Fattoruso S I S; Lopez M
Docetaxel in the adjuvant therapy of HER-2 positive breast cancer patients.
La Clinica terapeutica 2008;159(6):449-52.
2008: Fattoruso S I S; Rossi S; Vici P; Di Filippo F; Botti C; Di Lauro L; Foggi P; Saracca E; Ferranti F R; Visca P; Lopez M
[Optimal role of docetaxel in adjuvant chemotherapy for early stage HER2-negative breast cancer]
La Clinica terapeutica 2008;159(6):443-7.
2008: Fattoruso S I S; Rossi S; Di Lauro L; Botti C; Vici P; Lopez M
[Development of docetaxel in the adjuvant chemotherapy of breast cancer]
La Clinica terapeutica 2008;159(5):369-76.
2008: Metro Giulio; Fabi Alessandra; Russillo Michelangelo; Papaldo Paola; De Laurentiis Michelino; Ferretti Gianluigi; Pellegrini Domenica; Nuzzo Carmen; Graziano Vanessa; Vici Patrizia; Introna Marianna; Felici Alessandra; Cognetti Francesco; Carlini Paolo
Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.
Anticancer research 2008;28(2B):1245-58.
2008: Vici Patrizia; Di Lauro Luigi; Sergi Domenico; Foggi Paolo; Viola Giuditta; Mottolese Marcella; Giotta Francesco; Fattoruso Silvia I S; Corsetti Serena; Giannarelli Diana; Botti Claudio; Lopez Massimo
A phase II trial of docetaxel and vinorelbine in patients with advanced breast cancer previously treated with anthracyclines.
Oncology 2008;75(3-4):175-81.
2008: Folgiero Valentina; Avetrani Paolo; Bon Giulia; Di Carlo Selene E; Fabi Alessandra; Nisticò Cecilia; Vici Patrizia; Melucci Elisa; Buglioni Simonetta; Perracchio Letizia; Sperduti Isabella; Rosanò Laura; Sacchi Ada; Mottolese Marcella; Falcioni Rita
Induction of ErbB-3 expression by alpha6beta4 integrin contributes to tamoxifen resistance in ERbeta1-negative breast carcinomas.
PloS one 2008;3(2):e1592.
2007: Conti F; Carpano S; Sergi D; Di Lauro L; Amodio A; Vici P; Abbate M I; Ferranti F R; Viola G; Botti C; Foggi P; Sperduti I; Lopez M
[High-dose CEF (cyclophosphamide, epirubicin, fluorouracil) as primary chemotherapy in locally advanced breast cancer: long-term results]
La Clinica terapeutica 2007;158(4):331-41.
2006: Papaldo Paola; Ferretti Gianluigi; Di Cosimo Serena; Giannarelli Diana; Marolla Paolo; Lopez Massimo; Cortesi Enrico; Antimi Mauro; Terzoli Edmondo; Carlini Paolo; Vici Patrizia; Botti Claudio; Di Lauro Luigi; Naso Giuseppe; Nisticò Cecilia; Mottolese Marcella; Di Filippo Franco; Ruggeri Enzo Maria; Ceribelli Anna; Cognetti Francesco
Does granulocyte colony-stimulating factor worsen anemia in early breast cancer patients treated with epirubicin and cyclophosphamide?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(19):3048-55.
2006: Vici P; Capomolla E; Foggi P; Carpano S; Conti F; Paoletti G; Cauchi C; Giacinti L; Leonetti C; Giannarelli D; Lopez M
High activity of salvage treatment with biweekly paclitaxel-gemcitabine combination in heavily pretreated breast cancer patients.
Journal of experimental & clinical cancer research : CR 2006;25(1):39-44.
2005: Papaldo Paola; Lopez Massimo; Marolla Paolo; Cortesi Enrico; Antimi Mauro; Terzoli Edmondo; Vici Patrizia; Barone Carlo; Ferretti Gianluigi; Di Cosimo Serena; Carlini Paolo; Nisticò Cecilia; Conti Francesca; Di Lauro Luigi; Botti Claudio; Di Filippo Franco; Fabi Alessandra; Giannarelli Diana; Calabresi Federico
Impact of five prophylactic filgrastim schedules on hematologic toxicity in early breast cancer patients treated with epirubicin and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(28):6908-18.
2005: Vici Patrizia; Foggi Paolo; Colucci Giuseppe; Capomolla Elisabetta; Brandi Mario; Giotta Francesco; Gebbia Nicola; Di Lauro Luigi; Valerio Maria Rosaria; Paoletti Giancarlo; Belli Franca; Pizza Carmine; Giannarelli Diana; Lopez Massimo
Sequential docetaxel followed by epirubicin-vinorelbine as first-line chemotherapy in advanced breast cancer.
Anticancer research 2005;25(2B):1309-14.
2004: Brandi Mario; Vici Patrizia; Lopez Massimo; Valerio Maria Rosaria; Giotta F; Gebbia Nicola; Schittulli Francesco; Colucci Giuseppe;
Novel association with gemcitabine and docetaxel as salvage chemotherapy in metastatic breast cancer previously treated with anthracyclines: results of a multicenter phase II study.
Seminars in oncology 2004;31(2 Suppl 5):13-9.
2004: Botti Claudio; Buglioni Simonetta; Benevolo Maria; Giannarelli Diana; Papaldo Paola; Cognetti Francesco; Vici Patrizia; Di Filippo Franco; Del Nonno Franca; Venanzi Franco Maria; Natali Pier Giorgio; Mottolese Marcella
Altered expression of FAS system is related to adverse clinical outcome in stage I-II breast cancer patients treated with adjuvant anthracycline-based chemotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(4):1360-5.
2004: Papaldo Paola; Di Cosimo Serena; Ferretti Gianluigi; Vici Patrizia; Marolla Paolo; Carlini Paolo; Fabi Alessandra; Cognetti Francesco
Effect of filgrastim on serum lactate dehydrogenase and alkaline phosphatase values in early breast cancer patients.
Cancer investigation 2004;22(4):650-3.
2003: Papaldo Paola; Lopez Massimo; Cortesi Enrico; Cammilluzzi Eugenio; Antimi Mauro; Terzoli Edmondo; Lepidini Giuseppe; Vici Patrizia; Barone Carlo; Ferretti Gianluigi; Di Cosimo Serena; Nistico Cecilia; Carlini Paolo; Conti Francesca; Di Lauro Luigi; Botti Claudio; Vitucci Carlo; Fabi Alessandra; Giannarelli Diana; Marolla Paolo
Addition of either lonidamine or granulocyte colony-stimulating factor does not improve survival in early breast cancer patients treated with high-dose epirubicin and cyclophosphamide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(18):3462-8.
2002: Sciuto Rosa; Pasqualoni Rosella; Bergomi Serenella; Petrilli Germana; Vici Patrizia; Belli Franca; Botti Claudio; Mottolese Marcella; Maini Carlo L
Prognostic value of (99m)Tc-sestamibi washout in predicting response of locally advanced breast cancer to neoadjuvant chemotherapy.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 2002;43(6):745-51.
2002: Vici Patrizia; Colucci Giuseppe; Gebbia Vittorio; Amodio Antonella; Giotta Francesco; Belli Franca; Conti Francesca; Gebbia Nicola; Pezzella Giuseppe; Valerio Maria Rosaria; Brandi Mario; Pisconti Salvatore; Durini Ernesto; Giannarelli Diana; Lopez Massimo
First-line treatment with epirubicin and vinorelbine in metastatic breast cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(11):2689-94.
2002: Lopez Massimo; Vici Patrizia; Di Lauro Luigi; Carpano Silvia
Increasing single epirubicin doses in advanced soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1329-34.
2001: Vici P; Belli F; Di Lauro L; Amodio A; Conti F; Foggi P; Gionfra T; Morelli M F; Botti C; Ferraironi A; Lopez M
Docetaxel in patients with anthracycline-resistant advanced breast cancer.
Oncology 2001;60(1):60-5.
2000: Mottolese M; Benevolo M; Del Monte G; Buglioni S; Papaldo P; Nisticò C; Di Filippo F; Vasselli S; Vici P; Botti C
Role of P53 and BCL-2 in high-risk breast cancer patients treated with adjuvant anthracycline-based chemotherapy.
Journal of cancer research and clinical oncology 2000;126(12):722-9.
2000: Vici P; Amodio A; Di Lauro L; Conti F; Gionfra T; Belli F; Lopez M
First-line chemotherapy with vinorelbine and paclitaxel as simultaneous infusion in advanced breast cancer.
Oncology 2000;58(1):3-7.
1999: Carpano S; Amodio A; Bucher S; Foggi P; Vici P; Rinaldi M; Mariotti S; Del Monte G; Lopez M
[Chemotherapy of advanced stage melanoma using cisplatin, epirubicin and alpha-interferon]
La Clinica terapeutica 1999;150(2):109-14.
1998: Vici P; Conti F; Amodio A; Belli F; Della Giulia M; Mariotti S; Gionfra T; Lopez M
[Simultaneous infusion of vinorelbin and taxol as first-line chemotherapy in metastasized breast cancer]
La Clinica terapeutica 1998;149(4):255-9.
1998: Conti F; Vici P
[Vinorelbin in the treatment of breast cancer: current status and prospectives for the future]
La Clinica terapeutica 1998;149(921):61-74.
1998: Vici P; Ferraironi A; Di Lauro L; Carpano S; Conti F; Belli F; Paoletti G; Maini C L; Lopez M
Dexrazoxane cardioprotection in advanced breast cancer patients undergoing high-dose epirubicin treatment.
La Clinica terapeutica 1998;149(921):15-20.
1998: Lopez M; Vici P; Di Lauro K; Conti F; Paoletti G; Ferraironi A; Sciuto R; Giannarelli D; Maini C L
Randomized prospective clinical trial of high-dose epirubicin and dexrazoxane in patients with advanced breast cancer and soft tissue sarcomas.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(1):86-92.
1997: Maini C L; Sciuto R; Ferraironi A; Vici P; Tofani A; Festa A; Conti F; Lopez M
Clinical relevance of radionuclide angiography and antimyosin immunoscintigraphy for risk assessment in epirubicin cardiotoxicity.
Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology 1997;4(6):502-8.
1997: Maini C L; Tofani A; Sciuto R; Semprebene A; Cavaliere R; Mottolese M; Benevolo M; Ferranti F; Grandinetti M L; Vici P; Lopez M; Botti C
Technetium-99m-MIBI scintigraphy in the assessment of neoadjuvant chemotherapy in breast carcinoma.
Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1997;38(10):1546-51.
1997: Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega F M
Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients.
Journal of experimental & clinical cancer research : CR 1997;16(3):321-4.
1997: Vici P; Di Lauro L; Conti F; Capomolla E; Gionfra T; Amodio A; Lopez M
Paclitaxel activity in anthracycline refractory breast cancer patients.
Tumori 1997;83(3):661-4.
1996: Vici P; Di Lauro L; Carpano S; Amodio A; Pignatti F; Casali A; Conti F; Lopez M
Vinorelbine and mitomycin C in anthracycline-pretreated patients with advanced breast cancer.
Oncology 1996;53(1):16-8.
1995: Garaci E; Lopez M; Bonsignore G; Della Giulia M; D'Aprile M; Favalli C; Rasi G; Santini S; Capomolla E; Vici P
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a.
European journal of cancer (Oxford, England : 1990) 1995;31A(13-14):2403-5.
1995: Botti C; Vici P; Lopez M; Scinto A F; Cognetti F; Cavaliere R
Prognostic value of lymph node metastases after neoadjuvant chemotherapy for large-sized operable carcinoma of the breast.
Journal of the American College of Surgeons 1995;181(3):202-8.
1995: Lopez M; Vici P; Di Lauro L; Paoletti G; Gionfra T; Conti F; Carpano S; Pignatti F; Giannarelli D
Intrapatient comparison of single-agent epirubicin with or without lonidamine in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1995;31A(10):1611-4.
1995: Di Lauro L; Del Medico P; Carpano S; Cancrini A; Gionfra T; Vici P; Rosselli M; Lopez M
Sequential subcutaneous thymopentin, interferon alpha-2a and interleukin-2 in metastatic renal cell cancer.
Tumori 1995;81(1):42-4.
1994: Lopez M; Carpano S; Cavaliere R; Di Lauro L; Ameglio F; Vitelli G; Frasca A M; Vici P; Pignatti F; Rosselli M
Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1994;5(8):741-6.
1993: Lopez M; Carpano S; Cancrini A; Marcellini M; Del Medico P; Rinaldi M; Vici P; Paoletti G; Di Lauro L
Phase II study of continuous intravenous infusion of recombinant interleukin-2 in patients with advanced renal cell carcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1993;4(8):689-91.
1993: Lopez M; Natali M; Di Lauro L; Vici P; Pignatti F; Carpano S
Combined treatment with buserelin and cyproterone acetate in metastatic male breast cancer.
Cancer 1993;72(2):502-5.
1991: Vici P; Veltri E; Carpano S; Di Lauro L; Lopez M
[Buserelin therapy in postmenopausal patients with advanced breast carcinoma]
La Clinica terapeutica 1991;136(3):195-9.
1991: Lopez M; Carpano S; Di Lauro L; Vici P; Conti E M
Epirubicin and DTIC (EDIC) for advanced soft-tissue sarcomas.
Oncology 1991;48(3):230-3.
1991: Lopez M; Vici P; Carpano S; Natali M; Ganzina F; Conti E M; Di Lauro L
Combination chemotherapy with oral idarubicin and cyclophosphamide for metastatic breast cancer.
Journal of cancer research and clinical oncology 1991;117(1):61-4.
1990: Natali M; D'Aprile M; Tonini G; Leggio M; Vici P; Carpano S; Angelini F; Carassai A; Lopez M
[Fluorouracil and high-dose folinic acid in the treatment of advanced colorectal carcinoma]
La Clinica terapeutica 1990;134(1):25-30.
1990: Lopez M; Natali M; Di Lauro L; Tonini G; Carpano S; Vici P; Conti E M
5-Fluorouracil, epirubicin, and BCNU (FEB) in advanced measurable gastric cancer.
American journal of clinical oncology 1990;13(3):204-7.
1989: Lopez M; Contegiacomo A; Vici P; Dello Ioio C; Di Lauro L; Pagliarulo C; Carpano S; Giannarelli D; De Placido S; Fazio S
A prospective randomized trial of doxorubicin versus idarubicin in the treatment of advanced breast cancer.
Cancer 1989;64(12):2431-6.
1989: Lopez M; Papaldo P; Di Lauro L; Vici P; Carpano S; Conti E M
5-Fluorouracil, adriamycin, cyclophosphamide (FAC) vs. 5-fluorouracil, epirubicin, cyclophosphamide (FEC) in metastatic breast cancer.
Oncology 1989;46(1):1-5.
1987: Lopez M; Carassai A; Di Lauro L; Mignano M; Papaldo P; Vici P; Carpano S; Balice A; Di Gaetano G
[Colorectal carcinoma. II. Adjuvant therapy]
La Clinica terapeutica 1987;121(1):15-27.
1987: Lopez M; Carassai A; Di Lauro L; Papaldo P; Carpano S; Vici P; Mignano M; Di Gaetano G
[Colorectal cancer. I. Chemotherapy in the advanced stage]
La Clinica terapeutica 1987;120(6):473-87.
1986: Lopez M; Vici P; Balice A; Carpano S; Papaldo P; Di Lauro L
[Current status of osteosarcoma therapy]
La Clinica terapeutica 1986;117(5):409-25.
1986: Lopez M; Vici P; Carpano S; Balice A; Di Lauro L; Papaldo P
[Ewing's sarcoma: current status of its therapy]
La Clinica terapeutica 1986;116(5):403-13.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Patrizia Vici

Research Profile (preview)

Procedures

Disorders

Chemicals & Drugs

Concepts & Ideas

Physiology

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Patrizia Vici (preview)

All Publications